Castle Biosciences, Inc. · NASDAQ:CSTL

Maetzold Derek J sold 9,002 Castle Biosciences, Inc. shares (Form 4)

Traded Jul 1, 2026 · Filed Jul 6, 2026

On Jul 1, 2026, Maetzold Derek J (Director, Pres. & Chief Exec. Officer) sold 9,002 Castle Biosciences, Inc. shares at US$24.29 for US$219K under a trading plan, leaving 12,368 shares. Filed Jul 6, 2026 (Form 4).

Sold
9,002 shares
Price
US$24.29
Value
US$219K
Holding after
12,368 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Pres. & Chief Exec. Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Common StockOption exercise6,214US$2.3927,693Direct
Jul 1, 2026Common StockSale6,214US$24.2921,479Direct
Jul 1, 2026Common StockSale1,357US$24.2940,710Indirect
Jul 1, 2026Common StockSale1,153US$24.2934,602Indirect
Jul 1, 2026Common StockSale278US$24.2912,368Indirect

Source

View original at SEC

Related